Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China
· Delayed Price · Currency is CNY 5.55
+0.03 (0.54%)
Apr 29, 2026, 3:05 PM CST
SHE:002252 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 36,193 | 41,873 | 47,685 | 53,164 | 42,737 | 45,972 | Upgrade
|
| Market Cap Growth | -22.05% | -12.19% | -10.30% | 24.40% | -7.04% | -7.84% | Upgrade
|
| Enterprise Value | 37,991 | 42,775 | 43,990 | 48,939 | 39,357 | 42,858 | Upgrade
|
| Last Close Price | 5.52 | 6.32 | 7.17 | 7.87 | 6.21 | 6.65 | Upgrade
|
| PE Ratio | 23.00 | 26.55 | 21.74 | 29.88 | 22.73 | 35.51 | Upgrade
|
| Forward PE | 19.71 | 96.49 | 96.49 | 96.49 | 96.49 | 96.49 | Upgrade
|
| PS Ratio | 4.93 | 5.70 | 5.83 | 6.68 | 6.51 | 10.72 | Upgrade
|
| PB Ratio | 1.12 | 1.29 | 1.49 | 1.79 | 1.48 | 1.78 | Upgrade
|
| P/TBV Ratio | 1.54 | 1.78 | 1.81 | 2.19 | 1.79 | 2.21 | Upgrade
|
| P/FCF Ratio | - | - | - | 29.10 | 28.49 | 42.20 | Upgrade
|
| P/OCF Ratio | - | - | - | 23.34 | 24.77 | 35.53 | Upgrade
|
| PEG Ratio | - | 2.29 | 2.29 | 2.29 | 2.29 | 2.29 | Upgrade
|
| EV/Sales Ratio | 5.17 | 5.82 | 5.38 | 6.15 | 5.99 | 10.00 | Upgrade
|
| EV/EBITDA Ratio | 20.20 | 23.53 | 19.14 | 19.76 | 18.14 | 26.52 | Upgrade
|
| EV/EBIT Ratio | 23.06 | 26.80 | 21.02 | 21.13 | 19.79 | 29.31 | Upgrade
|
| EV/FCF Ratio | -53.24 | - | - | 26.79 | 26.24 | 39.34 | Upgrade
|
| Debt / Equity Ratio | 0.12 | 0.12 | 0.00 | 0 | 0 | 0 | Upgrade
|
| Debt / EBITDA Ratio | 2.51 | 2.14 | 0.01 | 0.00 | 0.00 | 0.01 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.00 | 0.00 | 0.01 | Upgrade
|
| Net Debt / Equity Ratio | 0.06 | 0.06 | -0.09 | -0.14 | -0.15 | -0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.32 | 0.99 | -1.29 | -1.69 | -1.94 | -1.83 | Upgrade
|
| Net Debt / FCF Ratio | -1.47 | -2.52 | 3.34 | -2.30 | -2.81 | -2.71 | Upgrade
|
| Asset Turnover | 0.19 | 0.21 | 0.25 | 0.26 | 0.23 | 0.16 | Upgrade
|
| Inventory Turnover | 0.90 | 0.97 | 1.22 | 1.37 | 1.14 | 0.78 | Upgrade
|
| Quick Ratio | 1.56 | 1.62 | 2.90 | 2.22 | 3.16 | 2.77 | Upgrade
|
| Current Ratio | 3.73 | 3.64 | 5.61 | 3.87 | 5.22 | 5.26 | Upgrade
|
| Return on Equity (ROE) | 4.08% | 4.90% | 7.12% | 6.08% | 6.85% | 5.05% | Upgrade
|
| Return on Assets (ROA) | 2.31% | 2.79% | 3.99% | 4.64% | 4.31% | 3.47% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.21% | 4.18% | 6.44% | 7.46% | 6.89% | 5.34% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.80% | 4.60% | 6.50% | 7.80% | 6.90% | 5.60% | Upgrade
|
| Earnings Yield | 4.36% | 3.77% | 4.60% | 3.35% | 4.40% | 2.82% | Upgrade
|
| FCF Yield | -1.97% | -1.70% | -1.86% | 3.44% | 3.51% | 2.37% | Upgrade
|
| Dividend Yield | 0.88% | 0.76% | 0.98% | 0.38% | 0.48% | 0.42% | Upgrade
|
| Payout Ratio | 16.40% | 16.40% | 20.05% | 11.36% | 10.04% | 13.02% | Upgrade
|
| Buyback Yield / Dilution | 0.51% | 0.51% | -0.39% | 2.23% | - | -5.28% | Upgrade
|
| Total Shareholder Return | 1.39% | 1.27% | 0.58% | 2.61% | 0.48% | -4.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.